NIOX Group Plc (AIM:NIOX)

London flag London · Delayed Price · Currency is GBP · Price in GBX
65.00
+2.00 (3.17%)
At close: Feb 27, 2026
3.50%
Market Cap 271.66M
Revenue (ttm) 46.00M
Net Income (ttm) 5.20M
Shares Out 417.94M
EPS (ttm) 0.01
PE Ratio 57.33
Forward PE 19.40
Dividend 0.01 (1.92%)
Ex-Dividend Date May 15, 2025
Volume 425,576
Average Volume 465,781
Open 63.00
Previous Close 63.00
Day's Range 62.50 - 65.96
52-Week Range 53.40 - 77.60
Beta -0.18
RSI 49.49
Earnings Date Apr 2, 2026

About NIOX Group

NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled Nitric Oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. N... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 2006
Employees 91
Stock Exchange London Stock Exchange AIM
Ticker Symbol NIOX
Full Company Profile

Financial Performance

In 2024, NIOX Group's revenue was 41.80 million, an increase of 13.59% compared to the previous year's 36.80 million. Earnings were 3.70 million, a decrease of -65.42%.

Financial Statements

News

There is no news available yet.